Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Clinical trial data paints a clear picture
Rogers-Bennett, L
Novo Nordisk, Eli Lilly and Company, Pfizer, and AstraZeneca are some of the key players in the market.
Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation
Retrieved 14 May 2022, from A Phase III, Multicentre, Double-Blind, Randomized, Placebo-Controlled Study to Confirm the Safety and Efficacy of Subcutaneous Bioresorbable Afamelanotide Implants in Patients with Erythropoietic Protoporphyria (EPP)
US$ 28.77
US$ 26.59
US$ 20.71
US$ 21.16
US$ 27.14
US$ 20.99
US$ 20.19
US$ 24.22
US$ 25.95
